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ABSTRACT Drosophila has long been a premier model for the development and application of cutting-edge genetic approaches.
The CRISPR-Cas system now adds the ability to manipulate the genome with ease and precision, providing a rich toolbox to
interrogate relationships between genotype and phenotype, to delineate and visualize how the genome is organized, to illu-
minate and manipulate RNA, and to pioneer new gene drive technologies. Myriad transformative approaches have already
originated from the CRISPR-Cas system, which will likely continue to spark the creation of tools with diverse applications. Here,
we provide an overview of how CRISPR-Cas gene editing has revolutionized genetic analysis in Drosophila and highlight key
areas for future advances.
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THROUGH more than a century of study and extensivedevelopment of genetic tools, Drosophila melanogaster
has become a premier system for understanding complex bi-
ological processes at the molecular, cellular, and organismal
levels. Despite this strength, until recently, making precise
modifications to the genome was challenging, labor inten-
sive, and had a low frequency of success. The first successful
genome-editing strategies induced homologous recombina-
tion through P-element excision, or the in vivo generation of
linear templates using multiple transgenic constructs (Gloor
et al. 1991; Banga and Boyd 1992; Rong and Golic 2000;
Gong and Golic 2003; Huang et al. 2008, 2009). More recent
strategies have relied on the generation of a targeted double-
strand break (DSB) in the genome to trigger DNA repair by
the cellular repair machinery—a process that can be co-opted
to precisely modify genomic sequences. Targeted DSBs were
first generated by programmable nucleases, either zinc-finger
nucleases (ZFNs; Bibikova et al. 2002) or transcription acti-
vator-like effector nucleases (TALENs; Liu et al. 2012). The
more recent co-option of highly programmable bacterial
adaptive immune systems for generating targeted DSBs has
resulted in an unprecedented level of control of the genome
of nearly any organism (Harrison et al. 2014). With this sim-
ple, two-component, clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas system, the researcher
need only provide a small targeting RNA, which is easily
synthesized, and the bacterial nuclease. Because all of these
genome-editing strategies rely upon the cellular DNA-repair
machinery, lessons learned from earlier approaches have
driven the rapid advance of CRISPR-based approaches.
CRISPR-Cas Systems in Bacterial Immunity
The first CRISPR locus was identified in 1987 based on its
highly repetitive sequence (Ishino et al. 1987), but it took
nearly 20 years until a definitive link was made between
these repeats and a role in adaptive immunity (Barrangou
et al. 2007). Impressively, it was only 6 years after this sem-
inal discovery that multiple groups published successful
co-option of the system for genome editing (Cong et al.
2013; Jinek et al. 2013; Mali et al. 2013b). In the short time
since the original demonstrations of genome editing using
the bacterial CRISPR-Cas system, it has rapidly become a
nearly universal tool in biological research. The continued
development of this system builds on understanding its fun-
damental role in bacterial and archaeal immunity.
TheCRISPRlocus isanarrayofalternatingrepeatsandspacer
sequences that essentially provides a chronological history of the
viruses and plasmids that have invaded a given bacterial strain
(Barrangou et al. 2007). CRISPR-based immunity involves three
steps that are all critical for protecting the bacteria from invad-
ing viruses: adaptation, expression, and interference (van der
Oost et al. 2009; Makarova et al. 2011). In the adaptation step,
fragments of foreign DNA are incorporated into the CRISPR
locus as new spacers. During expression, the transcription and
subsequent processing of the CRISPR locus provides an RNA
template for recognition of complementary protospacer se-
quences in the invading DNA. In the final interference step,
the invading DNA is cleaved and inactivated by an RNA-guided
Cas effector protein. To allow the immune system to distinguish
invader DNA from genomic DNA incorporated in the CRISPR
array, stable binding by the effector protein and subsequent
DNA cleavage requires a protospacer adjacent motif (PAM) pre-
sent only in the targeted DNA.
The constantly active arms race between virus and host has
resulted in a large amountof variation inCRISPR-Cas systems,
which are present in most archaea and about half of all bacteria
and currently divided into two classes, six types, and numerous
subtypes based on the complement of Cas genes associatedwith
the CRISPR locus (Makarova et al. 2011, 2015; Shmakov et al.
2015). Class 1 systems utilize a multi-protein effector complex
to cleave invading DNA. By contrast, class 2 systems require
only a single effector protein, and are therefore advantageous
for genome engineering when compared to the multi-protein
class 1 effector systems. The Cas effector protein most widely
used for genome editing is Cas9. More recently, the single effec-
tor Cpf1 has been demonstrated to be an effective tool for ge-
nome engineering (Zetsche et al. 2015a). Species-specific
features within a given type of CRISPR-Cas system have also
been used to diversify genome-engineering capabilities. Species-
specific variations of particular note for genome-editing pur-
poses include the recognition of different PAM sequences, which
expands the genomic sequences available for targeting, and the
size of the nuclease, with smaller variants being more easily
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delivered into cells (Gasiunas et al. 2012; Cong et al. 2013;
Esvelt et al. 2013; Hou et al. 2013; Kleinstiver et al. 2015; Ran
et al. 2015; Zetsche et al. 2015a). Thus, the rapid expansion in
the utility of this system for biological research and the thera-
peutic promise it holds is built on a foundation of research into
fundamental biological properties. The continued studies of the
varied mechanisms by which the CRISPR-Cas system provides
bacterial immunity will be essential for further developing this
powerful tool.
Detailed biochemical studies of the single Cas9 effector
from Streptococcus pyogenes defined a simple two-component
system for generating targeted DSBs (Jinek et al. 2012). This
simplified system requires only the Cas9 nuclease and a sin-
gle chimeric guide RNA (gRNA) programmed through a short
sequence that base pairs with complementary DNA in the
targeted genome to direct Cas9 cleavage (Figure 1). Because
it only requires that the researcher generate a single small
RNA easily tailored to a specific sequence, this system has
been rapidly adopted as the mechanism of choice for gener-
ating targeted DSBs. Furthermore, the identification of the
two nuclease domains required for generating double-strand
DNA breaks enabled the subsequent inactivation of one or
both domains to generate nickase and nuclease-dead ver-
sions of Cas9, respectively, which have been co-opted for
further manipulations of the genome (Gasiunas et al. 2012;
Jinek et al. 2012; Mali et al. 2013a; Qi et al. 2013; Ran et al.
2013). In this chapter, we will focus on how this continuously
evolving technology has been developed for use inDrosophila
and highlight specific areas that will be exciting for future
expansion.
CRISPR-Cas Components
The research community has rapidly adopted the CRISPR-
Cas9 system for genome engineering in large part because the
system is straightforward andeasy to use. Any laboratorywith
basic molecular biology expertise can readily generate the
required reagents, gRNAs, Cas9, and DNA donors, and the
delivery of these components is similarly straightforward.
Since there aremultiple print andweb-based resources that
provide step-by-step instructions on how to carry out a
Cas9-mediated genome-editing experiment in Drosophila
Box 1. Web-based CRISPR resources for researchers working with Drosophila
Addgene: addgene.org/crispr/drosophila
- repository of Cas9, gRNA, and donor plasmids; informational resources
Bloomington Drosophila Stock Center: flystocks.bio.indiana.edu/Browse/misc-browse/CRISPR
- repository of transgenic CRISPR-Cas9 stocks
CRISPR fly design: crisprflydesign.org
- descriptions and links for fly and molecular reagents, protocols, unpublished data
DRSC/TRiP Functional Genomics Resources: fgr.hms.harvard.edu
- descriptions and links for fly and molecular reagents, Cas9-modified cell lines, protocols, a curated selection of publications,
and resources in development for the fly community
DGRC: dgrc.bio.indiana.edu
- repository of Cas9, gRNA, and donor plasmids
FlyBase:CRISPR: flybase.org/wiki/FlyBase:CRISPR
- a compendium of resources, including links to target sequence search programs, repositories of fly strains and vectors, and
additional links of interest; a curated selection of methods papers and reviews
flyCRISPR: flycrispr.molbio.wisc.edu
- descriptions and links for fly and molecular reagents, protocols, unpublished data
Insect Genetic Technologies Research Coordination Network: igtrcn.org
- highlights of recent genome engineering advances
NIG-FLY FlyCas9: shigen.nig.ac.jp/fly/nigfly/cas9
- repository of Cas9 and transgenic gRNAs fly strains and related molecular reagents; protocols
Online programs for target identification
CCTop: crispr.cos.uni-heidelberg.de
CHOPCHOP: chopchop.cbu.uib.no
CRISPOR: crispor.tefor.net/
CRISPR Optimal Target Finder: tools.flycrispr.molbio.wisc.edu/targetFinder
CRISPRscan: crisprscan.org
E-CRISP: e-crisp.org/E-CRISP
Find CRSPRs: flyrnai.org/crispr2
Cas9 Target Finder: shigen.nig.ac.jp/fly/nigfly/cas9/cas9TargetFinder.jsp
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(Bassett and Liu 2014; Housden et al. 2014; Gratz et al.
2015a,b; Housden et al. 2016; Housden and Perrimon
2016a,b,c,d; Port and Bullock 2016b); see Box 1), here
we provide a general overview of the applications of CRISPR
that highlights the resources available to fly researchers, and
discuss the results of tool-development studies that may im-
prove the outcomes of genome-editing experiments.
Genomeengineering approaches usingZFNs, TALENs, and
CRISPR are all based on the premise that inducing double-
strand DNA breaks at targeted sites will force the cell to repair
the break, opening awindowof opportunity formodifying the
original sequence during the repair process. Thus, all CRISPR
experiments require Cas9 to induce a double-strand DNA
break. Cas9 can be injected as DNA, mRNA, or protein, or
transgenically expressed. These options have been reviewed
extensively elsewhere (Bassett and Liu 2014; Housden et al.
2014, 2016; Gratz et al. 2015a,b; Housden and Perrimon
2016a,b,c,d; Port and Bullock 2016b). We note that all strat-
egies are functional, but that transgenic Cas9 sources yield
the highest efficiency of engineering. Several groups have
created transgenic lines that express Cas9 under the control
of various enhancers and promoters to influence when and
where genome editing occurs. Strains that express Cas9 in
the germline can be used to generate heritable mutations,
although there is evidence that Cas9 is likely active in the
soma of many of these reportedly germline-specific trans-
genic strains, with the possible exception of a nos-Cas9 strain,
which may be important to consider in the case of cell-lethal
manipulations (Port et al. 2014; Ren et al., 2013; Gratz et al.,
2014). It is also important to recognize that maternal depo-
sition of Cas9 can modify the embryonic genome in the pres-
ence of gRNA (Lin and Potter 2016b). Thus, even progeny
that do not inherit the Cas9 transgene are subject to editing if
the mothers express Cas9 in the germline. More recently,
researchers have explored using the Gal4-UAS system for
expressing Cas9 in somatic tissues in combination with gRNAs
to generate tissue-specific knockouts (Port et al. 2014; Xue
et al. 2014; Port and Bullock 2016a). On a cautionary note,
there is some evidence that Cas9 by itself has toxic effects
when expressed at high levels using binary expression systems
(Port et al. 2014; Port and Bullock 2016a). To address this,
there have been some efforts in flies to limit Cas9 activity by,
for example, dialing down UAS-driven expression levels (Port
and Bullock 2016a). Others, working mainly in mammalian
cell lines, have reported alternate strategies to regulate Cas9
activity using optogenetic and chemical-induction approaches
(Hemphill et al. 2015; Nihongaki et al. 2015; Zetsche et al.
2015b).
The second obligate component of all CRISPRexperiments
is a gRNA for targeting Cas9 to a specific sequence. gRNAs can
be targeted to different regions of a gene to obtain a variety of
desired outcomes. For example, a gRNA targeting a coding
region can be used to create a loss-of-function allele, or a pair
of gRNAs flanking a gene can generate a deletion. gRNAs find
their target via 18- to 20-nt sequences that base-pair with
complementary genomic DNA (Figure 1). In designing a
gRNA, the goal is to identify an 18- to 20-nt sequence in
the genomic-target region that is both adjacent to a PAM site
and unique, or, at a minimum, has limited similarity to other
sequences in the genome that might be subject to off-target
cleavage. As discussed in more detail below, target sites as
close as possible to intended edits are preferred. The fre-
quency at which the PAM sequence occurs in a genome will
define the number and position of target sequences. Multiple
web-based gRNA target sequence search engines, including
several created by fly researchers, can be used to identify high
quality target sequences (Box 1). Guidelines for designing
the most efficient gRNAs are still under investigation, and it
remains to be determined how well guidelines based on data
collected from cultured mammalian cells and other organ-
isms apply to designing gRNAs for Drosophila (Farboud and
Meyer 2015; Malina et al. 2015; Moreno-Mateos et al. 2015;
Doench et al. 2016; Haeussler et al. 2016). Nonetheless, a
number of studies suggest that the gRNAs that cleave most
effectively have higher than average GC content and low U
content [note that poly(T) stretches should be avoided since
these may signal transcription termination]. Yet even the best-
designed gRNA will be rendered ineffectual by a SNP in the
target sequence or PAM. Thus, it is critical to sequence the
target region in the genome of the fly strain being engineered
Figure 1 Adoption of the CRISPR-Cas sys-
tem for two-component genome editing.
(A) A Cas effector protein is targeted to a
PAM-containing DNA target by a crRNA and
tracrRNA. The invading DNA is subsequently
cleaved by the RuvC and HNH nuclease do-
mains, generating a DSB. (B) A two-component
system composed of Cas9 and a single chimeric
gRNA can cleave genomic DNA containing a
PAM sequence. Target specificity is determined
by the 20 nucleotides at the 59 end of the
gRNA, allowing the researcher to program
Cas9 cleavage.
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rather than rely on the reference genome sequence. While
gRNAs with multiple predicted off-targets should be avoided
in general, when establishing engineered animal lines off-
target effects are less of a concern than in cells because it is
possible to eliminate these events by outcrossing. Thus, only
potential off-target sites positioned close to the target site
are of significant concern for Drosophila researchers gener-
ating engineered fly lines.
gRNAs are commonly supplied as RNAs or plasmids. To
generate deletions, or target two or more genes simulta-
neously, multiple gRNAs can be supplied (Gratz et al. 2014).
Researchers working in a variety of systems, including flies,
have co-opted ribozymes to liberate multimerized gRNAs
that are expressed under the control of a single promoter
(Gao and Zhao 2014; Xie et al. 2015; Port and Bullock
2016a). Similarly, work done in flies showed that encoding
tRNAs along with the gRNAs enables processing of multiple
gRNAs from a single transcript and may enhance cell-
specific gene editing outcomes of an individually expressed
gRNA (Port and Bullock 2016a). gRNAs can also be trans-
genically expressed. When designing experiments using in-
tegrated gRNAs, the possible generation of a genedrive that
can be propagated throughout a population must be consid-
ered. As discussed in detail in the section Active Genetics,
genedrives are powerful mechanisms to introduce genome
edits that propagate by non-Mendelian inheritance. Because
genedrives can drastically alter allele frequencies in popu-
lations, they pose an ecological risk and are not suitable
for standard genome editing experiments. While CRISPR
genedrives are only beginning to become subject to institu-
tional biosafety precautions to ensure their containment, amul-
tidisciplinary group of researchers recently came together to
draft recommendations for their safe use (Akbari et al. 2015).
When properly designed, integrated gRNAs can be useful
tools; however, particular attention must be paid when gener-
ating lines that transgenically express both Cas9 and a gRNA.
The final component of a CRISPR experiment is a DNA
donor template for introducing specific edits or exogenous
sequences. Donor templates, which are only required in a
subset of CRISPR experiments, are discussed below.
Co-Opting Cellular Repair Events for Genome Editing
Cells employ twomajor pathways to repair double-strandDNA
breaks, nonhomologous end joining (NHEJ) and homology-
directed repair (HDR), and both can be co-opted for genome
editing (Figure 2). [For an in-depth discussion of DNA repair
events and processes, see the FlyBook chapter on DNA repair
(Sekelsky 2017)]. Here, we briefly outline the key consider-
ations for CRISPR gene editing. NHEJ and related pathways
repair broken DNA ends by ligation. Because NHEJ does not
use a homologous DNA template for restoring the original se-
quence, insertions and deletions (indels) often occur at the
breakpoint. Thus, NHEJ-based approaches are well suited for
generating loss-of-function alleles by targeting breaks to crit-
ical genomic sequences and selecting for disruptive repair
events. A major advantage of this approach is that these ex-
periments are straightforward to design and execute, requiring
only that the researcher supply Cas9 and a gRNA to direct DNA
cleavage to a specific site in the genome. To disrupt protein
function, NHEJ experiments are often designed with a single
gRNA that targets cleavage within the coding region of a gene
followed by selection of flies with frame-shifting indels (Figure
2 and Figure 3). Use of a single gRNA to generate indels by
NHEJ can similarly be applied to interrupt noncoding ele-
ments. An alternate strategy is to supply two gRNAs to delete
the sequences between the two targeted sites. In Drosophila,
deletions up to 15 kb have been achieved in this way, and
Figure 2 CRISPR-Cas9 catalyzed genome engineering. Cas9 is guided to specific sequences in the genome by a programmable gRNA where it cleaves
both DNA strands to create DSBs. The cell uses two main pathways to repair DSBs—NHEJ and HDR—both of which can be co-opted for genome editing.
Templates for HDR can be single- or double-stranded exogenous DNA, the sister chromatid, the homologous chromosome, or even highly related
paralogous sequences elsewhere in the genome.
Manipulating the Fly Genome with CRISPR-Cas 5
larger deletions are likely feasible (Gratz et al. 2014). Themost
labor-intensive step inNHEJ-based genome editing is the iden-
tification of engineered lines of interest, which, in the absence
of a recognizable phenotype, requires molecular character-
ization of candidates. The use of coconversion approaches
can reduce the workload. In coconversion, a visible marker
is targeted along with the gene of interest, and only those
flies showing the visible phenotype are analyzed molecu-
larly based on the assumption that these are the flies in
which the CRISPR-Cas system was active (Ward 2015; Ge
et al. 2016).
The second major cellular DNA repair pathway, HDR,
employs homologous DNA as a template for DNA synthesis
to bridge the gap across aDSB. The fact that this pathway uses
a template for repair provides an opportunity for the engi-
neering of specific sequence changes through the introduction
of a donor repair template (Figure 2 and Figure 3). HDR has
been appropriated to make a wide variety of precise modifi-
cations, including the introduction of sequence substitutions,
the generation of conditional alleles, and the incorporation of
protein tags. Targeting the HDR pathway requires, in addi-
tion to Cas9 and an appropriately targeted gRNA, a donor
repair template comprising the new sequences flanked by
DNA homologous to the sequences adjacent to the cleavage
site (commonly called homology arms) for recognition by the
broken genomic DNA ends.
Two types of DNA donors have been used to successfully
engineer the Drosophila genome: single-stranded DNA (ssDNA)
donors, often referred to as ssODNs, and double-stranded
DNA (dsDNA) donors (Figure 3). To ensure the incorpora-
tion of the desired editing event it is essential to consider
the directionality inherent in the DNA repair process when
designing the donor template, particularly with ssDNA do-
nors. ssDNA donors are oligonucleotides that require only
short homology arms (60 nt) for efficient HDR. The ma-
jor advantage of ssDNA donors is that they can be rapidly
and inexpensively synthesized. However, synthesized single-
stranded oligonucleotides are size limited, so their use is re-
stricted to small modifications such as minimal base-pair edits
or the incorporation of short peptide tags. The size limit of
ssDNAs also precludes incorporation of markers to facilitate
screening for engineered flies, so molecular or phenotypic
screening is required. In contrast, dsDNA donors, which
must be supplied as circular plasmids to escape degradation,
can incorporate large DNA sequences to facilitate the gen-
eration of a great variety of genome modifications. The pri-
mary drawback of dsDNA donors is that they are more labor
intensive to generate, and require larger homology arms of
0.5–1 kb for efficient editing. Markers for visible screening,
such as 3xP3-DsRed, which enables rapid screening for
DsRed expression in the eye, are commonly incorporated
into dsDNA donors and greatly facilitate identification of
engineered lines (Bischof et al. 2007; Gratz et al. 2014).
When flanked by LoxP or FRT recombinase sites, markers
can be readily removed to minimize alterations to the engi-
neered locus. Alternatively, they can be retained to provide a
Figure 3 Flowchart of the experimental design options for editing the genome using CRISPR-Cas9. While repair by NHEJ and HDR is observed in most
cases, other DNA repair pathways such as NHEJ-related microhomology-mediated end joining (MMEJ) may also repair Cas9-induced DSBs. Different
sources of Cas9 and gRNA can be used in combination; for example, a gRNA-expressing plasmid can be injected into transgenic flies expressing Cas9.
Transgenic flies that express Cas9 are readily available at stock centers. Cas9 can also be supplied as a protein. Modified with permission from Gratz
et al. (2015b).
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marked allele. Scarless approaches for removing screenable
markers have also been developed (S. Gratz and K. M. O’C.-G.,
unpublished data, flycrispr.molbio.wisc.edu). In this approach,
the visible marker is flanked by piggyBac transposon inverted
repeat sequences, and either inserted at an endogenous TTAA
site or incorporated into a TTAA site in the introduced se-
quences. With donors designed to recapitulate the duplica-
tion of the TTAA site that normally occurs during piggyBac
insertion, piggyBac transposase-mediated removal of the
visible marker results in restoration of a single TTAA site.
Whether usingdsDNAor ssDNAdonors, anoften-unavoidable
source of scars arises from the need to edit DNA donors to
prevent their gRNA-directed cleavage byCas9 either before or
after successful editing. This is generally done by introducing
mutations thatdisrupt thegRNAtarget and/orPAMsequence.
Although sometimes the desired edit itself disrupts the target
sequence and will prevent cleavage, the majority of genome-
editing experiments result in the introduction of both an exper-
imentally relevant mutation as well as a mutation designed to
block further cleavage by Cas9. Because amajor goal of genome
engineering is to limit the introductionof ancillary changeswhen
modifying the genome, strategies have been developed to
eliminate these cleavage-blocking mutations. These ap-
proaches necessarily involve a two-step process: in the first
step, the experimentally relevant mutation and cleavage-
blocking mutation are introduced; in the second step, the
cleavage-blocking mutation is reverted to the wild-type se-
quence. One scar-removal approach developed in cultured
mammalian cells takes advantage of a Cas9 nuclease that has
been engineered to recognize an altered PAM (Kleinstiver
et al. 2015). In the first engineering step, the PAM recog-
nized by wild-type Cas9 is mutated to the PAM recognized
by the engineered Cas9. In the second step, the engineered
Cas9 is used to target the mutant PAM sequence, which can
then be reverted to wild type with an appropriate DNA do-
nor template. A conceptually similar system that relies on a
visible marker, rather than two forms of Cas9, has been de-
veloped for evolutionary studies in Drosophila species (Lamb
et al. 2017). Scar removal may not be necessary for all exper-
iments, but these strategies provide valuable means to elimi-
nate unwanted ancillary mutations when desired.
In designing an HDR experiment, selection of the ideal
gRNA target site requires balancing specificity and location.
Because partial incorporation of donor sequences can and
does occur, cleavage sites closer to the desired edit generally
result in more efficient incorporation of sequence changes.
Another strategy is to place the selection marker distal to the
desired edit such that repair events resulting in marker in-
corporation will necessarily encompass the desired edit as
well. Donor design also influences efficiency, and has been
studied in early Drosophila genome engineering studies with
ZFNs, and inmammalian cell lines where HDR is less efficient
than in theDrosophilagermline (Beumer et al.2013;Richardson
et al. 2016). One notable recent study found that ssDNA donors
complementary to the nontargeted strand with asymmetric ho-
mology arms yielded the highest HDR rates in cells (Richardson
et al. 2016). Because these results are explained by the nature of
Cas9-DNA interactions, it is likely theywill apply to gene editing
in Drosophila as well. A growing mechanistic understanding of
Cas9 function is likely to lead to additional advances in the
rational design of gene editing experiments.
It is important to emphasize that while the experimenter
supplies the reagents necessary for targeting a particular DNA
repair pathway and selects for desired outcomes, the cell
determines how the CRISPR-generated break is repaired.
The predominant repair pathway used depends on cell type,
developmental stage, and cell cycle. Donor configuration and
locus-specific effects also likely influence repair pathway
selection in ways that are currently poorly understood. Mu-
tations that block one pathway would be expected to shift
repair to the other pathway. Indeed, previous work demon-
strated that mutations in lig4, encoding a ligase with a key
role in NHEJ, biases repair toward HDR (Beumer et al. 2008;
Bozas et al. 2009). However, this does not appear to be the
case for CRISPR-mediated experiments in flies, but may be an
effective strategy if combined with knockdown of Mus308, a
polymerase that mediates lig4-independent end joining, as
recently demonstrated in Drosophila tissue culture. (Gratz
et al. 2014; Ge et al. 2016; Kunzelmann et al. 2016). The
development of strategies to control or bias the cellular repair
employed by the cell is an important goal for more precise
genome engineering.
Finally, it is critical to recognize that anytime chromosomal
DNA breaks are induced, unexpected rearrangements can
occur during the repair process. Thus, it is necessary to
conduct a full molecular characterization of all engineered
lines. One common undesired event that should be noted is
crossover repair during HDR, which results in the incorpora-
tion of the dsDNA donor plasmid backbone (the regions out-
side of the homology arms). In our experience, crossover
repair occurs with sufficient frequency that we now incorpo-
rate a visiblemarker in the backbone of all our donor plasmids
for selecting against backbone incorporation (K. M. O’C.-G.,
unpublished data; see flyCRISPR.molbio.wisc.edu for details
and reagents). An advantage of ssDNA donors is that they are
not subject to this complicating repair event.
Current and Future Applications of CRISPR-Cas
in Drosophila
The adoption of CRISPR-Cas systems for gene editing has
led to the rapid expansion of clever genomic manipulations
for probing gene function and the development of additional
Cas-based tools to interrogate genomes. Many of these ap-
proaches are now being combined with existing Drosophila
tools and techniques to synergistic effect. Here, we highlight
these and other CRISPR-Cas applications of interest to Dro-
sophila researchers.
Modular access to the genome
Functional understanding of a gene and the processes it reg-
ulates is advancedbyavarietyofgeneticmodifications, ranging
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from deletion of the gene to incorporation of function-probing
point mutations to the insertion of molecular tags. Thus, the
desire to repeatedly edit loci of interest has driven the devel-
opment of modular genome editing approaches. The most
commonly employed strategies in flies take advantage of
FC31 recombinase, which mediates recombination between
attP and attB sites. One versatile strategy is the replacement of
a targeted genewith a single attP “docking” site for subsequent
FC31-mediated incorporation of any number of engineered
versions of the gene (Huang et al. 2009). Originally developed
for use with earlier homologous recombination techniques,
this approach has since been coupled with CRISPR for rapid
gene replacement and repeated access to the targeted locus
(Huang et al. 2009; Gratz et al. 2013, 2014). In a related
modular approach, called recombination mediated cassette
exchange (RMCE), attP-flanked genomic DNA or integrated
exogenous DNA can be readily exchanged with compatible
attB-flanked cassettes. RMCE has been leveraged in several
approaches to obtain modular access to the genome, many
of which have been combined with CRISPR. For example,
CRIMIC is a large-scale effort to expand the MiMIC collection
(for a detailed discussion, see the FlyBook chapter on Gene
Tagging). Briefly,MiMICs are attP-flanked cassettes nested in a
specialized Minos transposon for integration into the genome,
frequently into introns. MiMIC elements have been hopped
around the genome and selected for incorporation in useful
positions near genes, where RMCE has been used to incorpo-
rate cassettes that allow for the knock-down of gene expres-
sion and generation of protein traps that report the expression
of targeted genes. By combining CRISPR and MiMIC, CRIMIC
provides access to genes missed by transposon mobilization
and those lacking introns. A similar approach allows genetic
access to cells expressing targeted genes through the incorpo-
ration of modular donor exons containing viral T2A and Gal4
coding sequences. This approach, called Plug and Play, relies
on T2A-mediated ribosomal skipping to yield Gal4 expression
in the pattern of the host gene (Diao et al. 2015). The CRISPR-
Cas9 system has also been used to replace transgenic elements
previously incorporated into the fly genome; for example, Ho-
mology Assisted CRISPR Knock-in (HACK) was developed to
repurpose the large number of well-characterized Gal4 en-
hancer traps available in Drosophila for the orthogonal QF2
binary expression system (Lin and Potter 2016a).
Additional Cas enzymes expand the reach of CRISPR
Because the need for a defined PAM limits the number of
sequences that can be targeted byCas9 nucleases, efforts have
been directed at developing genome-editing systems that can
beused,aloneor incombination, totargetanygenomicsequence.
The most commonly used S. pyogenes Cas9 requires an NGG
PAM sequence, which varies in frequency between organ-
isms, and between genomic regions within species. The num-
ber of sequences that can be targeted for genome editing has
been expanded in three different ways. First, researchers
have isolated Cas9 proteins from additional bacterial species,
such as Neisseria meningitidis, that use divergent PAM
sequences (Esvelt et al. 2013; Hou et al. 2013). Second, S.
pyogenes Cas9 has been engineered to recognize noncanonical
PAM sequences (Kleinstiver et al. 2015). Third, a Cas enzyme,
Cpf1, from a type V CRISPR-Cas system that relies on the PAM
sequence (T)TTN has been isolated from Staphylococcus aureus
and used to edit the genomes of eukaryotic cells (Zetsche et al.
2015a; Kleinstiver et al. 2016; Port and Bullock 2016a). Cpf1
also has the advantage of being smaller than Cas9, making it
easier to manipulate and transfect into cultured cells. One recent
study adapted Cpf1 for use in Drosophila and found that the
Cpf1-mediated cleavage frequency was reduced in comparison
to Cas9-mediated cleavage (Port and Bullock 2016a). Thus, in
Drosophila, Cpf1 may largely be used as an alternative approach
that will be particularly useful for targeting A/T rich genomic
regions lacking NGG motifs. Studies are underway to character-
ize new Cas-like proteins, while other efforts will increase the
targeting capacity and efficiency of the current repertoire of Cas
enzymes through protein engineering.
Modified Cas9 and gRNAs expand gene editing and enable
targeting of proteins to DNA
Multiple approaches take advantage of mutant Cas9 proteins
inwhich one or both nuclease domains have been inactivated.
Mutating justonenucleasedomaincreatesanickaseversionof
Cas9.Created to reduceoff-targetmutations, nickaseCas9has
been used by itself and in pairs to introduce single- and DSBs,
respectively, to edit the genome (Mali et al. 2013a; Ran et al.
2013). Nickase Cas9 is seldomused inDrosophila because of the
greatly reduced frequency at which desired modifications are
recovered in comparison to wild-type Cas9 and the capacity to
readily eliminate off-target mutations by outcrossing (Port et al.
2014; Ren et al. 2014). In mammalian cells, nickase Cas9 has
also been used as a platform to create a nucleotide “base editor”
that harnesses the base-excision repair pathway to generate
C:G-to-T:A mutations (Komor et al. 2016). Thus, mutant Cas9
can be co-opted to trigger specific DNA-repair pathways in ad-
dition to less error-prone DSB or nickase repair pathways for
genome-editing purposes.
Nuclease-inactive Cas9 (dCas9) has proven to be a readily
adaptable platform to probe genome function and structure in
a variety of ways (Figure 4). In these approaches, the major-
ity of which were pioneered in cultured cells, dCas9 is fused
to an effector protein, such as a transcriptional regulator or
fluorescent protein, and guided to specific nucleic acid se-
quences by a gRNA. This platform has enabled diverse strat-
egies to manipulate and visualize DNA. Nuclease-inactive
Cas9 was first developed as a platform to regulate gene ex-
pression (Qi et al. 2013), and many of the dCas9-based tools
subsequently developed have been used for this purpose in
both cultured cells and organisms, including fruit flies. The
initial studies of dCas9 discovered that the inactive nuclease
itself could disrupt gene expression, likely by steric inhibition
of RNA polymerase (Qi et al. 2013). Approaches to inhibit
gene expression using dCas9 rapidly expanded to include
dCas9 fused to various transcriptional repressors and chro-
matin modifiers (Dominguez et al. 2016). These dCas9-based
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tools for inhibiting gene expression are often collectively re-
ferred to as “CRISPRi.” In contrast, dCas9-fusion proteins
designed to activate endogenous gene expression gained
the moniker “CRISPRa.” CRISPRa and CRISPRi have both
been adapted for use in Drosophila (Chavez et al. 2015; Lin
et al. 2015; Ghosh et al. 2016). Like other genetic tools,
CRISPRa and CRISPRi are not without drawbacks: off-target
effects are a concern, as Cas9 binding appears to be more
promiscuous than Cas9 cleavage, and CRISPRa may be lim-
ited in its ability to increase the expression of a gene that is
already highly expressed (Lin et al. 2015). Nonetheless,
CRISPRa and CRISPRi offer advantageous newmeans to con-
trol gene expression in flies. Advantages of CRISPRa and
CRISPRi are their potential to target genes that are difficult
to manipulate using Gal4-UAS or RNAi, such as large, com-
plex genes with multiple isoforms or genes that produce non-
coding RNAs, and the potential to tune expression levels
more precisely than possible with binary expression systems.
A collection offly stocks for genome-wideCRISPRa is currently
under development (B. Ewen-Campen and N. Perrimon, per-
sonal communication). CRISPRa andCRISPRi can also be used
tomodulate the expression ofmultiple genes at the same time.
While the CRISPRa and CRISPRi tools currently adapted for
use in Drosophila have a unidirectional effect on target genes
(i.e., the targeted genes are either all turned on or all turned
off), researchers have developed approaches in cultured cells
to differentially regulate the expression of multiple genes si-
multaneously (e.g., to enhance the expression of one gene at
the same time the expression of another gene is repressed).
These approaches rely on the fusion of different transcriptional
regulators to distinct dCas9-effector proteins with different
PAM specificities (Esvelt et al. 2013). In an effort to gain
additional spatial and temporal control over gene regula-
tion, dCas9 has also been developed as an optogenetic tool
(Polstein and Gersbach 2015). In this approach, which uses
the light-sensitive dimer of the CRY2 and CIB1 plant proteins
to bring together dCas9 and its effector, the dCas9-mediated
effect on gene expression is regulated by exposure to blue
light. This approach has been named light-activated CRISPR-
Cas9 effector, or LACE. The dCas9 platform will undoubtedly
continue to facilitate the development of new approaches to reg-
ulate gene expression with temporal and spatial precision.
The dCas9 platform has also been developed as a tool to
visualize genomic loci by bringing fluorophores to targeted
sequences (Chen et al. 2013). Combining dCas9 from different
bacteria species has enabled the illumination of multiple loci
simultaneously (Ma et al. 2015; Chen et al. 2016). Since the
detection of single molecules of fluorescent proteins in cells is
challenging, typically multiple dCas9-GFP fusion proteins must
be targeted to the locus of interest (Chen et al. 2013). While
repetitive sequences, such as telomeres, can be visualized using
as few as two gRNAs, multiple gRNAs are necessary to detect
nonrepetitive loci (Chen et al. 2013). The challenge of visualiz-
ing genomic loci with just a few gRNAs may be overcome by
recent advances in molecular tags. For example, the SunTag,
which is composed of a multimerized peptide sequence that is
recognized by a GFP-tagged nanobody, has been fused to dCas9
to enhance visualization of genomic loci (Tanenbaum et al.
2014). It is likely that the split-GFP strategy, which is also ame-
nable to multimerization, will be similarly useful in visualizing
genomic loci (Kamiyama et al. 2016). While these techniques
are currently under development in cell culture systems, it is
reasonable to expect they will be transferable to Drosophila for
dissecting the distribution and dynamics of genomic loci.
Figure 4 Cas9 and the gRNA as platforms for manipulating and visualizing the genome. (A) dCas9 or nickase Cas9 can be fused to a diverase array of
proteins to regulate gene expression, visualize genomic loci, and modify local DNA or chromatin. (B) RNA sequence can be added to the minimal gRNA
to recruit proteins, fluoresce, or affect RNA-specific functions.
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Following the successful, broad application of dCas9 as a
platform to interrogate genome function and dynamics,
gRNAs have recently been engineered as modular platforms
to regulate gene expression and visualize genomic loci
through the recruitment of transcriptional regulators and
fluorescent proteins (Shechner et al. 2015; Zalatan et al.
2015; Cheng et al. 2016; Fu et al. 2016; Ma et al. 2016a;
Wang et al. 2016) (Figure 4). By attaching different protein-
binding RNA motifs to gRNAs, unique combinations of pro-
teins can be recruited to different nucleic acid targets. For
example, it is possible to use this approach to activate and
inactivate different target genes at the same time. By attach-
ing MS2 stem loops to one gRNA and PP7 hairpins to another
gRNA, different transcriptional regulators can be recruited to
individual target genes to obtain specific transcriptional out-
comes. This approach has also been applied to visualize up to
six loci simultaneously by taking full advantage of the ability
to mix andmatch RNA aptamer and fluorescent protein pairs,
using a combinatorial approach to expand the color options
beyond red, green, and blue (Ma et al. 2016b). The tech-
niques described here likely represent just the first of many
ways in which Cas9- and gRNA-based platforms will be adap-
ted to interrogate the function and localization of genomic
sequences.
CRISPR-based approaches for targeting RNA
There is a keen interest in developing CRISPR-based reagents
to targetRNA,with thegoals of visualizingRNA localization in
cells, improving RNA knock-down efficacy, and otherwise
manipulating endogenous RNAs (e.g., regulating splicing or
translation; reviewed in Nelles et al. 2015). To this end, several
approaches have been developed over the past couple years:
first, it was discovered that supplying an exogenous PAM in
the form of a DNA oligonucleotide (called a “PAMmer”) was
sufficient to redirect the S. pyogenes gRNA and Cas9 complex
away from genomic DNA to an RNA target (O’Connell et al.
2014; Sternberg et al. 2014). In the presence of a PAMmer,
the targeted RNA was cleaved and the gRNA and Cas9 did
not target the corresponding genomic sequence. This approach
was recently adapted to visualize cellular RNAs using dCas9
fused to a fluorescent protein (Nelles et al. 2016). However,
the PAMmer requires a specific 59 chemical modification to
avoid degradation by RNase H that cannot be genetically
encoded, limiting its potential use in vivo. Second, a Cas protein,
C2c2, that specifically targets RNA was recently character-
ized (Abudayyeh et al. 2016). Analogous to Cas nucleases
that target DNA, C2c2 can be programmed to target a spe-
cific RNA sequence; however, once C2c2 is activated fol-
lowing target cleavage, the enzyme remains active and
cleaves nontarget RNAs, ultimately causing cell death.
There are intriguing ways in which C2c2 could be har-
nessed to eliminate specific cell populations within an or-
ganism to determine how a subset of cells functions (e.g.,
neuronal circuit mapping) or to remove unwanted cells
(e.g., cancer-causing cells and tumors). However, the C2c2
system cannot currently be applied to selectively remove
individual RNA transcripts from cells. Thus, CRISPR-based
approaches to target specific RNAs in vivo await development.
Cell Culture Strategies, Screens and Future Directions
While studies inDrosophila have pioneered the use of CRISPR-
mediated genome engineering in organisms, technologies
for manipulation and screening in tissue culture have been
more extensively developed in mammalian systems. Thus,
the many strategies established in mammalian cells provide
a framework for future use inDrosophila tissue culture andwill
complement RNAi-based screening platforms. Encouragingly,
Cas9-induced DSBs have been successfully harnessed for both
NHEJ and HDR in S2 cells, despite the fact that these cells are
largely tetraploid (Bassett et al. 2013; Bottcher et al. 2014; Lee
et al. 2014; Housden et al. 2015; Kunzelmann et al. 2016).
Successful experiments have relied on the U6 promoter driv-
ing gRNA expression from either plasmids or PCR products,
and have found an optimal gRNA length of 18–19 nucleo-
tides. While transient transfection of constitutively expressed
Cas9 resulted in gene editing, the frequency of the desired
event was low (Bassett et al. 2013; Bottcher et al. 2014;
Housden et al. 2015). Multiple strategies have been employed
to overcome this low efficiency: (1) experiments have been
performed in cell lines stably expressing Cas9 (Bottcher et al.
2014); (2) cells expressing Cas9 have been selected using
puromycin (Bassett et al. 2013); and (3) individual cells have
been sorted into conditioned media (Housden et al. 2015).
Strategies that rely on selection or prior integration of a
Cas9-expression cassette donot require optimization of sorting
protocols that allow recovery of single cells, but have the dis-
advantage of maintaining continuous expression of Cas9,
which may confound downstream experiments. Together,
these experiments have, for the first time, enabled rapid
generation of knockout Drosophila cell lines. Importantly,
while off-target events can be genetically removed when
engineering organisms, they represent a significant concern
in cell culture experiments and their likelihood must be
strongly considered when designing gRNAs and screening
for editing events.
Successful creation of epitope-tagged genes in S2 cells has
been achieved using both plasmid and PCR-based donors
coupled with selection (Bassett et al. 2013; Bottcher et al.
2014; Kunzelmann et al. 2016). PCR-generated donors require
only 60 bp of homology flanking the desired modification on
either side, whereas plasmid-based donors optimally contain
1-kb homology arms (Bottcher et al. 2014; Kunzelmann et al.
2016). PCR-generated donors,which unfortunately do notwork
in vivo, presumably because the linear templates are quickly
degraded, are easily constructed by ordering gene-specific pri-
mers and using publically available plasmids as templates.
Downstream removal of an FRT-flanked selectablemarker using
FLP recombinase has enabled successful addition of epitope tags
with minimal disruption to the DNA sequence (Bottcher et al.
2014; Kunzelmann et al. 2016). Nonetheless, development of
the piggyBac-based method to scarlessly remove the selectable
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marker will improve the system. Coupling Cas9-mediated ge-
nome engineeringwith RNAi targeting both lig4 andmus-308 to
suppress NHEJ has been shown to further increase efficiency of
HDR repair events (Kunzelmann et al. 2016). Because off-target
integration events can occur, and can result in cells that are
resistant to selection, confirmation of successful tagging of the
desired locus is important.
The CRISPR system has provided a powerful platform for
screening inmammalian tissue culture, andwill likely provide
an important addition to RNAi-based screening in Drosophila
cells. Many screens in mammalian systems are based on NHEJ-
mediated mutation coupled with selection for a specific
phenotype, and have been used to identify mutations that
confer resistance to chemotherapeutics, bacterial toxins and
DNA-damaging agents (Koike-Yusa et al. 2014; Shalem et al.
2014; Wang et al. 2014; Zhou et al. 2014). These screens
use pooled libraries consisting of multiple gRNAs targeting
each gene and high-throughput sequencing to identify
those gRNAs specifically enriched or depleted following
selection. Similar screens have recently been made possi-
ble in Drosophila cells with the production of a library con-
sisting of.40,000 gRNAs targeting 13,501 genes (Bassett
et al. 2015). While these pooled libraries have significant
strengths, they require screens to be based on selections.
Future generation of arrayed libraries in which individual
gRNAs are arranged in a multi-well format will provide a plat-
form similar to the current RNAi libraries, and will expand the
kinds of screens that can be performed (Hartenian andDoench
2015). CRISPRi and CRISPRa provide additional screening
strategies that have proven powerful in mammalian tissue
culture, and lay the groundwork for similar loss-of-function
and gain-of-function screens in Drosophila cell lines in the
future (Lin et al. 2015; Shalem et al. 2015). As with the variety
of strategies being developed to engineer the genome in vivo
using CRISPR-based approaches, continued advances will en-
able rapid and reproducible manipulation of the genome in
tissue culture and new screening platforms.
Active Genetics
Mendelian inheritance is characterized by two salient fea-
tures: independent chromosome assortment and genetic link-
age of loci that reside in proximity on the same chromosome.
These twobasic elements of standard inheritance are typically
etched in theminds of trained geneticists, and, as such, can be
compared to dedicated computer hardware. Thus, it may at
first present a challenge to such experts to fully appreciate the
impact of emerging active genetic technologies based on self-
copying elements guided by the CRISPR-Cas9 system that
entirely bypass these traditional rules.
In this section, the concept behind active genetic elements
willbesummarized,emphasizingthetransformationalpotential
that this technology offers with regard to methods for targeted
transgenesisand facilitatingcombinatorialgenetics. Inaddition,
the use of CRISPR-Cas9 technology to generate active genetic
elements that can copy themselves with high efficiency to the
homologous chromosome duringmeiosis will be discussed. It is
important to recognize that other non-Mendelian systems of
inheritance have been knownandexploited for quite some time
(e.g., transposons, homing-endonuclease genes, and balanced
translocations, to name but a few), and the rapidity of new
innovation will likely create myriad modifications and add-
ons to the basic strategies outlined below. For the purposes of
this chapter, however, active genetics refers to the use of tar-
geted gene-editing systems, such CRISPR-Cas9, to generate
self-propagating transgenic elements.
The mutagenic chain reaction: a potent combination of
mutagenesis and genedrive
In early 2015, a proof-of-concept study demonstrated the
autocatalytic CRISPR-Cas9 mediated genetic transmission
of an element in which genes encoding Cas9 and a gRNAwere
inserted as a cassette into the genome precisely at the location
targeted by the gRNA (Gantz and Bier 2015) (Figure 5A). The
linkage of these editing components and their integration into
the targeted locus resulted in both high-efficiency somatic mu-
tation and germline transformation. This method was named
the mutagenic chain reaction (MCR) in analogy to the polymer-
ase chain reaction (PCR) to emphasize that MCR could result in
the doubling of selected DNA sequences in vivo in the sameway
that PCR does in vitro. Since this first experimental demonstra-
tion of MCR transmission, germline propagation of similar con-
structs have been observedwith high efficiency in yeast (DiCarlo
et al. 2015) andmosquitoes (Gantz et al. 2015; Hammond et al.
2016) (see below). Since genedrives rely on germline transmis-
sion, it is important to consider the repair processes that are
active in the germline and drive propagation at non-Mendelian
frequencies.
An interesting question to pose to novice students in
genetics that illustrates the novel behavior of active genetic
elements is to askhow theymightusepurely genetic criteria to
map an ideally behaving MCR element to a chromosome and
then relative to known genetic markers? SinceMCRelements
are transmitted toall offspring, it is notpossible touse traditional
measures of recombination frequency to assign chromosome
location or linkage to known reference markers. In Drosophila,
with its rich trove of genetic tools, there is of course a solution:
cross the MCR element to a deficiency collection and identify a
deletion that results in standard Mendelian inheritance of the
element. Indeed, this novel way of moving genetic information
in the form of active-genetic elements is likely to be a powerful
tool for future studies.
Why might active genetic elements copy so efficiently via
the germline?
The ability of an element or genetic allele to be inherited
more frequently than the expected Mendelian frequency of
50% is often referred to as meiotic drive, or, more recently, as
genedrive. At a very simplistic level, the striking frequency at
which active genetic elements are transmitted can be attrib-
uted to a strong bias in the germline toward repairing double
stranded breaks by HDR vs. the competing error-prone NHEJ
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pathway (Gantz and Bier 2015; Gantz et al. 2015; Hammond
et al. 2016). However, this explanation glosses over several
important factors, detailed discussion of which lies beyond
the current chapter, but which have been well reviewed by
others (Chapman et al. 2012; Anand et al. 2013; Baudat et al.
2013; Keeney et al. 2014; Haber 2015). In the following
section, key insights into HDR vs. NHEJ repair as they pertain
to efficient genedrive are summarized.
Briefly, as described above, HDR and NHEJ act as mutually
antagonistic pathways at several different levels, resulting in
the repair process being restricted to one or the other pathway
(Figure 2). The repair process used can be influenced by
central transcription and DNA-repair determinants. For ex-
ample, the mammalian Brca1/53P regulators cross inhibit
each other in a dose-dependent fashion. Additionally, there
are mutual inhibitory mechanisms that regulate the forma-
tion of complexes required for initiating the two competing
repair pathways (Rad51-mediated strand invasion followed
by single-stranded DNA resection vs. Ku70/Ku80 blunt-end
capping and bridging) (Chapman et al. 2012). Importantly,
the decision of which repair pathway to use is under quite
different control in somatic cells vs. the germline. Although
data on how DNA breaks will typically be repaired in somatic
cells carrying active genetic elements are minimal at this
time, much of this repair may occur via NHEJ (see genedrive
section for evidence supporting this view inmosquitoes). This
question will be important to address in future studies. With
regard to HDR, several other processes are layered over the
core HDR machinery shared by germline and somatic cells.
For example, in somatic cells, HDR is primarily used to fix
DNA breaks resulting from errors in DNA replication, and acts
predominantly in a postreplicative fashion to repair lesions
from one chromosome with the sequence present on the iden-
tical sister chromatid. Although repair using the nonidentical
chromosome homolog can also occur in somatic cells, this pro-
cess is generally repressed, most likely to avoid loss of hetero-
zygosity, which can lead to various disorders, including cancer.
In contrast, during the first meiotic prophase, where again
Figure 5 Active genetic systems for genome editing. (A) The MCR results in the autocatalytic copying of an MCR element to the homologous
chromosome. (B) CopyCat elements carry a gRNA(s), which results in the insertion of the CopyCat element at the target site. CopyCat
elements can include a COI, such as Gal4, UAS, or an attP site. CopyCat elements require an unlinked Cas9 to copy. A COI can also
be included in the MCR cassette (A) or trans-complementing drive cassette (C). (C) A trans-complementing drive consists of two elements:
one element comprised of just Cas9, and a second element comprised of gRNAs. One gRNA targets the site at which Cas9 is integrated
and one targets the site of gRNA integration, facilitating copying of both the gRNA(s) and Cas9. The genedrive potential of each active
genetic approach is indicated.
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HDR acts following replication, the bias is to fix DSBs from the
homologous chromosome. During meiosis I, actively induced
double-stranded DNA breaks are repaired by invasion of the
homologous chromosome to establish crossover events that
are essential for tethering these chromosomes together and
for subsequent proper chromosomal segregation. The great
majority of these meiotic HDR events, however, are resolved
without crossover, leading to gene conversion events, and such
events are likely responsible for propagating MCRs or other
active-genetic alleles.
Another important consideration is that, in the germline,
there are additional meiotic checkpoint processes that ensure
full suppression of the NHEJ pathway (Joyce et al. 2012).
Thus, HDR in the germline has evolved specifically to repair
DSBs from the homologous chromosome, and then resolve
the majority of these events through gene conversion. These
unique aspects of repair in the germline most likely form the
basis for why active genetic elements are so efficiently copied
to the homologous chromosome in the germline. Thus, al-
though strong genedrive has only been documented thus
far in yeast and insects (DiCarlo et al. 2015; Gantz and Bier
2015; Gantz et al. 2015; Hammond et al. 2016), it seems
highly probable that the process will be similarly efficient in
all organisms that undergo sexual recombination, including
vertebrates and plants. This prediction will undoubtedly be
validated or falsified in the near future by ongoing efforts to
extend active-genetic strategies to other organisms.
Split Cas9:gRNA transgenesis systems for accelerating
combinatorial genetics
Use of full MCR-like genedrive elements for experimental
purposes will most likely remain limited due to potential
ecological dangers posed by the inability to regulate the
copying process, and to the extreme care that must be taken
in handling such elements responsibly (Akbari et al. 2015).
Thus, as described below, implementation of such systems
will primarily be restricted to devising and testing genedrive
systems in various disease vectors or pest species. MCR ele-
ments may also prove of significant value for gaining genetic
access to pioneer species for which few tools (e.g., balancer
chromosomes or existing recessive alleles) are available apart
from genome sequence data. Nonetheless, in many instances,
split systems that separate the Cas9 and gRNA(s) may also be
adequate for such purposes. The two-component nature of
the CRISPR-Cas9 system offers flexibility in the configuration
of the components, which should be of general use to the
design of active-genetic systems.
One of the largest impacts of active genetics will likely be
the use of split Cas9:gRNA transgenesis systems to edit the
genome at multiple places simultaneously.We have proposed
such a system and named it CopyCat (Gantz and Bier 2016).
In the CopyCat system, the Cas9 source is a traditional Men-
delian transgene located at a separate genomic locus from the
gRNA-containing vector, which is inserted at the gRNA cut
site (denoted as,gRNA.wherein the brackets indicate that
the gRNA will be copied in the presence of Cas9; Figure 5B).
CopyCat elements can be designed to incorporate the same
features as transposon or FC31-mediated integration, includ-
ing FC31 docking sites, UAS sequences, various dominant-
marker genes, and other cassettes of interest (COI). CopyCat
elements also offer the potential to accelerate the assembly of
complex genotypes, or to generate trans-complementing sys-
tems that enable the active copying of both the gRNA and Cas9
(Figure 5C). Following the desired assembly of transgenic
elements, the separate source of Cas9 can be segregated
away from the active genetic elements returning standard
genetic control over the experiment. (Note that the converse
is not true: one cannot simply outcross the strain to remove
the CopyCat element since all progeny will inherit the element
in the presence of Cas9. As a standard safety precaution,
we recommend that stocks carrying CopyCat element(s) be
housed separately from those carrying Cas9 to avoid the
potential release of strains harboring even these weak
genedrives.)
CopyCat elements can be designed to carry either one or
two gRNAs, and can be used to either insert sequence via a
single cut or to replace a genomic interval through two cuts,
whichwould eliminate the interveninggenomic sequence and
replace it with the “cargo” sequence carried by the CopyCat
element. In this way, vectors carrying GAL4 or UAS sequences
could be inserted into the genome in a site-directed manner
using a gRNA carried on the same vector. Since the insertion
of sequence relies on the cell’s endogenous DNA repair ma-
chinery, the size of the DNA that can be inserted may be
limited, and the sequence inserted should be verified to en-
sure that no errors were incorporated. Indeed, in many cases
it may be possible to retrofit existing frequently used trans-
genic elements. Determining the site of genomic insertion
and inserting a gRNA that cuts very near the vector-insertion
site into the original transgene would endow the repurposed
transgene with active-genetic properties. It is possible that
the imprecise match of the cut and vector insertion sites will
reduce copying efficiencies. However, precedent from yeast
(Cho et al. 2014) and flies (Do et al. 2014) would suggest
that, so long as the cut site is within HDR-mediated resection
distance of the vector insertion, copying should take place.
Nonetheless, proof of this suggestion will need to be deter-
mined empirically.
The ability to insert and/or replace genetic elements at
specific genomic sites, and then to combine the products of
such modifications without regard to chromosomal location
or requirement for balancer chromosomes has the potential to
revolutionize the analysis of both coding and cis-regulatory
components of genes, and their cooperative interactions
in gene regulatory networks. In addition, it should be pos-
sible to combine design features accommodating both
genomic engineering and active-genetic strategies to en-
able facile modifications or replacements of large chromo-
somal intervals. Development of such tools should facilitate
the next generation of genetic manipulation of complex
loci, allowing control of both simple and complex genetic
traits.
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Genedrive systems and accessory elements
The idea of using genedrive systems to combat vectors of
disease or pest species has a long history dating back to the
1960s (Curtis 1968), and the theory behind such approaches
has been well developed (Curtis 1968; Burt 2003; James
2005; Deredec et al. 2008; North et al. 2013; Burt 2014).
In-depth discussion of this topic is thus well beyond the scope
of the chapter. Nonetheless, recent Cas9-based genedrive
experiments in mosquitoes highlight the potential of such
systems, and interesting lessons have already been gleaned
from the few published cases describing such systems that
may have more general implications (Gantz et al. 2015;
Hammond et al. 2016).
Lessons learned from mosquito vector suppression vs.
modification schemes
Two general schemes have been proposed to combat vector-
borne diseases, often referred to as suppression (killing the
vector host) or modification (preventing the disease agent
frombeingpropagatedby thehost but leaving thehost intact).
While proof of principle for both schemes has recently been
demonstrated in Anopheline mosquitoes that serve as key
vectors of malaria, populations in the wild may rapidly evolve
resistance due to a number of features, including natural
variationingRNA-targetsequenceandsequence-alteringNHEJ
repair events (Drury et al. 2017; Unckless et al. 2017). In
Anopheles stephensi, a genedrive system was devised that
carries a sophisticated gene cassette that induces anti-
parasite effector genes (single-chain antibodies recogniz-
ing invariant epitopes on the plasmodium parasite fused to
a Cecropin killing moiety following females feeding on a
blood meal; Isaacs et al. 2012). This large gene cassette
(17 kb), when transmitted via themale germline, propagates
to 99.5% of the progeny, which corresponds to 98–99% ef-
ficiency of copying itself to the homologous chromosome. In
contrast, in females this same element only converted the
homologous chromosome 10–20% of the time. Similarly, in
An. gambiae, a simple suppression genedrive element tar-
geting genes required for female fertility was passed with
much higher efficiency via males than females (Hammond
et al. 2016).
An alternative to creating a one-component full genedrive
element is a trans-complementing drive configuration (Figure
5C). In this arrangement, the Cas9 provided is a Mendelian
source and can be linked to various COIs, such as antipath-
ogen transgenes, or gRNAs targeting host factors. The second
element, which also behaves in Mendelian fashion on its
own, carries two gRNAs (as well as possible COIs). One of
the gRNAs cuts at its own site of chromosomal insertion, and
the other gRNA cuts at the site of Cas9 insertion. When two
such matched strains are crossed to each other, the result is a
self-propagating two-component drive system. The advan-
tages of this system include the ability to test and compare
many different Cas9 and gRNA combinations, to carry more
and varied cargo than a single drive, and to safely store the
component lines (separately housed) as Mendelian rather
than full-drive elements.
Why might transmission via the male vs. female germline
result in such differing conversion efficiencies in mosquitoes?
The likely answer seems to be that when the element is passed
viamales crossed towild-type females, the egg contains no Cas9
(which is under the control of the vasa promoter that is active in
both male and female germline lineages). In contrast, when a
female carrying the genedrive element is crossed to a wild-type
male, Cas9 is present throughout the egg (since Cas9 does not
become concentrated in pole cells post-translationally as the
Vasa protein does). Since the gRNA is expressed under the con-
trol of a ubiquitous U6 promoter, in progeny of females carrying
the genedrive element, active Cas9/gRNA complexes can form
in the egg prior to segregation of the germline. During the pre-
blastoderm stage, cells are somatic in nature, and Cas9-induced
DNA breaks can be repaired by either the NHEJ or HDR path-
ways. If NHEJ is used, often it will result in an indel mutation at
the DNA-cut site that precludes any further cutting. When such
an allele is created in a cell that subsequently gives rise to a germ
cell lineage (i.e., a pole cell), it will no longer be a substrate
for HDR-mediated gene conversion, and hence will block
copying of the active genetic element to the homologous
chromosome. While the requirement for excluding Cas9 ac-
tivity from embryonic cells prior to germline segregation
may vary between organisms, this issue is likely to be im-
portant to consider when designing active-genetic elements.
Hitchhiking elements
It is alsoworthnoting thatCopyCat elements canbe combined
with a full MCR drive element, in which case the element will
copy along with the full-drive element. When used in this
fashionwe refer to such elements as Construct Hitchhiking on
the Autocatalytic Chain Reaction (or CHACRs) as they chase
after the drive (Gantz and Bier 2016). CHACRs could be used
to update genedrive systems. For example, CHACRs could
combat the evolution of various forms of resistance to effec-
tors by introducing new protective gene cassettes into a
population of vector organisms that already have a Cas9-
based genedrive in place. Alternatively, CHACRs could carry
gRNAs that cut a nonpreferred allelic variant. As an example
of this latter application, which we refer to as CopyCutting,
one might include a gRNA that cuts an insecticide resistant
form of a host gene (e.g., encoding the Na+ ion channel or
Cyp450 genes) but not the wild-type sensitive form. When
such an element drives through a population, if it encounters an
insecticide resistant form, it should cut that chromosome and
repair it using the sensitive allele as a template, thus rendering
all the progeny insecticide sensitive. Similarly, CopyCutting
could be used in agriculture to cut a nonpreferred allele (e.g.,
a drought-sensitive allele) and replace with a drought-resistant
form. This would be particularly advantageous in polyploid
crop species such as wheat. Thus, one could cross an indi-
vidual carrying Cas9 and a CopyCutting gRNA generated in
the background of a resistant strain to a standard drought-
sensitive cultivar. The result should be conversion of all
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alloalleles to the resistant form. If two such strains were
then crossed to each other, the result would be combination
of both of the desired alleles across all of the alloalleles. The
unlinked Cas9 source could also be segregated out at this
stage to create a non-GMO organism with desired alleles (at
least as defined by US standards).
Outlook/Future Directions
The ability to readily modify the fly genome is significantly
changing the course of research inDrosophila. Cas9-mediated
genome engineering and active-genetic strategies are likely
to have a transformative impact on genetics as we currently
conceive of the field. Researchers working with fruit flies rely
heavily on transgenic approaches for diverse applications,
ranging from analyzing gene regulation to determining pro-
tein function and localization. While transgenic approaches
will remain a core strength ofDrosophila genetics, the CRISPR-
Cas system now provides the ability to directly edit endoge-
nous genomic sequences and precisely incorporate exogenous
DNA, which will undoubtedly lead to a new generation of
experimental approaches. The CRISPR-Cas system also holds
the potential to expand the range of forward genetic screens
through approaches in which Cas9 is used to introduce muta-
tions in combination with gRNA libraries, or in which inactive
Cas9 or a gRNA platform is exploited to recruit mutagenic
enzymes, such as cytidine deaminase or mini-singlet oxygen
generator, to specific genomic regions (Noma and Jin 2015;
Komor et al. 2016). In our experience, one remaining technical
hurdle lies in designing an effective gRNA. Since identifying
gRNAs that cleave efficiently and precisely in vivo remains a
trial-and-error process, we propose that the fly community
establish a database of validated gRNA sequences. This would
be an invaluable resource for the repeated manipulation of
individual genes, and it is also possible that the compiled se-
quences would reveal new parameters for designing gRNAs
that are effective in Drosophila. Along these lines, it is impor-
tant to note that laboratories in Boston, Heidelberg, and Kyoto
are coordinating independent efforts to generate gRNA librar-
ies to disrupt gene function in vivo (M. Boutros, B. Ewen-
Campen, S. Kondo, N. Perrimon, F. Port, and J. Zirin, personal
communication). While CRISPR-based tool development to
date has predominantly focused on gene function and visual-
ization, a recent study took advantage of Cas9-induced muta-
tions to generate DNA barcodes that can be used to trace cell
lineages in a developing zebrafish embryo (McKenna et al.
2016). This study highlights the potential for gene-editing
technologies to improve and expand existing techniques
used to analyze cell and developmental processes. Active
genetics has the potential to transform genetic manipula-
tion in many species and will certainly impact the implemen-
tation of genedrive systems to combat vector borne disease in a
broad variety of pest species. Based on the mechanism of
germline-mediated HDR repair of DNA breaks it seems likely
that active genetics will be highly efficient in virtually all
sexually reproducing species so long as Cas9 expression is
restricted to themale germline. If active genetics can be readily
adapted to other species it may also serve as an efficient site-
directed form of transgenesis. The success of the initial Cas9-
mediated genedrive experiments, suggests that this application
of active genetics will likely have a large impact. Nonetheless,
this necessitates pending regulatory and public approval of such
uses following the continued discussion of these applications. In
summary, the broad variety of applications covered here provide
only a glimpse into the myriad ways researchers are likely to
apply CRISPR-Cas approaches to address fundamental biologi-
cal questions. As it has for .100 years, Drosophila will un-
doubtedly continue to be influential in the development and
creative application of these new genetic technologies.
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